Docking prediction of levodopa in the receptor binding domain of spike protein of SARS-CoV-2
Biological and Biomedical Sciences
Levodopa is a prodrug that is converted into dopamine, which replenishes the deficient dopamine in the brain of patients suffering from Parkinsonism. We hypothesize that levodopa may interact with the receptor binding domain of the SARS-CoV-2 and may act as a physical impediment to the viral entry into the host cell.
ACS Pharmacology & Translational Science
Baig, A. M.,
(2021). Docking prediction of levodopa in the receptor binding domain of spike protein of SARS-CoV-2. ACS Pharmacology & Translational Science, 4(1), 406-409.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_bbs/904